Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Brand Name :
Besponsa
(United States) [Available]Synonyms :
inotuzumab
Class :
Antineoplastics and other
Dosage Forms & Strengths
Injection- lyophilized powder for reconstitution
0.9mg per vial
Acute Lymphoblastic Leukemia(All)
Cycle 1 -total dose include 1.8 mg per m2 per cycle
Day-1 0.8 mg per m2 IV
Day-8 0.5 mg per m2 IV
Day-15: 0.5 mg per m2 IV
The maximum duration of therapy for Cycle 1 is 21 days or can be continued to 28 days and 7-day treatment on Day 21.
for Subsequent Cycles:
patients who achieve a CR or CRi, a dose of 1.5 mg per m2 per cycle is recommended:
Day-1, 0.5 mg per m2 given IV
Day-8, 0.5 mg per m2 given IV
Day-15, 0.5 mg per m2 given IV
The maximum duration of therapy is 28 days, and seven days of treatment given on the 21st day
For patients who didn't succeed in CR or CRi, a dose of 1.8 mg per m2 per cycle is recommended:
-On day 1, 0.8 mg per m2 IV
-On day 8, 0.5 mg per m2 IV
-On day 15, 0.5 mg per m2 IV
The maximum duration of therapy is 28 days and seven days of treatment on Day 21
patients who didn't succeed in CR or CRi within three cycles should discontinue therapy
inotuzumab: they may enhance the QTc-prolonging effect of QTc-prolonging agents
inotuzumab: they may enhance the QTc-prolonging effect of QTc-prolonging agents
inotuzumab: they may enhance the QTc-prolonging effect of QTc-prolonging agents
inotuzumab: they may enhance the QTc-prolonging effect of QTc-prolonging agents
inotuzumab: they may enhance the QTc-prolonging effect of QTc-prolonging agents
when both drugs are combined, there may be an increased QTc interval
when both drugs are combined, there may be an increased QTc interval
when both drugs are combined, there may be an increased QTc interval
when both drugs are combined, there may be an increased QTc interval
when both drugs are combined, there may be an increased QTc interval
when both drugs are combined, there may be an increased QTc interval
when both drugs are combined, there may be an increased QTc interval
when both drugs are combined, there may be an increased QTc interval
when both drugs are combined, there may be an increased QTc interval
when both drugs are combined, there may be an increased QTc interval
when both drugs are combined, there may be an increased QTc interval
when both drugs are combined, there may be an increased QTc interval
when both drugs are combined, there may be an increased QTc interval
when both drugs are combined, there may be an increased QTc interval
when both drugs are combined, there may be an increased QTc interval
when both drugs are combined, there may be an increased QTc interval
when both drugs are combined, there may be an increased QTc interval
when both drugs are combined, there may be an increased QTc interval
when both drugs are combined, there may be an increased QTc interval
when both drugs are combined, there may be an increased QTc interval
when both drugs are combined, there may be an increased QTc interval
when both drugs are combined, there may be an increased QTc interval
when both drugs are combined, there may be an increased QTc interval
when both drugs are combined, there may be an increased QTc interval
when both drugs are combined, there may be an increased QTc interval
when both drugs are combined, there may be an increased QTc interval
when both drugs are combined, there may be an increased QTc interval
when both drugs are combined, there may be an increased QTc interval
when both drugs are combined, there may be an increased QTc interval
when both drugs are combined, there may be an increased QTc interval
when both drugs are combined, there may be an increased QTc interval
when both drugs are combined, there may be an increased QTc interval
when both drugs are combined, there may be an increased QTc interval
when both drugs are combined, there may be an increased QTc interval
when both drugs are combined, there may be an increased QTc interval
when both drugs are combined, there may be an increased QTc interval
when both drugs are combined, there may be an increased QTc interval
when both drugs are combined, there may be an increased QTc interval
when both drugs are combined, there may be an increased QTc interval
Adverse drug reactions:
Frequency defined
>10%
Thrombocytopenia
Neutropenia
Infection
Fatigue Hemorrhage
Leukopenia
Pyrexia
Nausea
Headache
Infection
Febrile neutropenia
Transaminases increased
Anemia
Abdominal pain
Lymphopenia
Diarrhea
Lymphopenia
Vomiting
Stomatitis
Alkaline phosphatase increased
Decreased appetite
Chills
Pregnancy warnings:
Breastfeeding warnings:
Pregnancy Categories:
Patient Information Leaflet
Generic Name: Inotuzumab (Rx)
Pronounced: IN-oh-TOOZ-ue-mab
Why do we use Inotuzumab?
Inotuzumab is an anticancer drug that treats relapsed or refractory B-cell precursor acute lymphoblastic leukemia.